Cargando…

AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization

Immune responses to inactivated vaccines against avian influenza are poor due in part to lack of immune memory. Adjuvants significantly increased virus neutralizing titers. We performed comprehensive analyses of polyclonal antibody responses following FDA-approved adjuvanted H5N1-A/Indonesia vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khurana, Surender, Coyle, Elizabeth M., Manischewitz, Jody, King, Lisa R., Gao, Jin, Germain, Ronald N., Schwartzberg, Pamela L., Tsang, John S., Golding, Hana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167326/ https://www.ncbi.nlm.nih.gov/pubmed/30302282 http://dx.doi.org/10.1038/s41541-018-0076-2

Ejemplares similares

Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization
por: Khurana, Surender, et al.
Publicado: (2015)

Heterologous Prime-Boost Vaccination with MF59-Adjuvanted H5 Vaccines Promotes Antibody Affinity Maturation towards the Hemagglutinin HA1 Domain and Broad H5N1 Cross-Clade Neutralization
por: Khurana, Surender, et al.
Publicado: (2014)

Monoclonal Antibody Targeting Neutralizing Epitope on H5N1 Influenza Virus of Clade 1 and 0 for Specific H5 Quantification
por: He, Fang, et al.
Publicado: (2013)

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses
por: Li, Tingting, et al.
Publicado: (2022)

A Rapid Flp-In System for Expression of Secreted H5N1 Influenza Hemagglutinin Vaccine Immunogen in Mammalian Cells
por: Lu, Hanxin, et al.
Publicado: (2011)

Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus
por: Khurana, Surender, et al.
Publicado: (2010)

Human H5N2 Avian Influenza Infection in Japan and the Factors Associated with High H5N2-Neutralizing Antibody Titer
por: Ogata, Tsuyoshi, et al.
Publicado: (2008)

Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes
por: Rajesh Kumar, Subaschandrabose, et al.
Publicado: (2017)

Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine
por: Van Reeth, Kristien, et al.
Publicado: (2023)

Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM(+) Memory B Cells
por: Throsby, Mark, et al.
Publicado: (2008)

Kinetics of Neutralizing Antibodies in Patients Naturally Infected by H5N1 Virus
por: Buchy, Philippe, et al.
Publicado: (2010)

Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus
por: Buchy, Philippe, et al.
Publicado: (2011)

Higher titers of some H5N1 and recent human H1N1 and H3N2 influenza viruses in Mv1 Lu vs. MDCK cells
por: Hamilton, Sara B, et al.
Publicado: (2011)

Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
por: Leroux-Roels, Isabel, et al.
Publicado: (2008)

Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets
por: Khurana, Surender, et al.
Publicado: (2009)

Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity
por: Ross, Kathleen A, et al.
Publicado: (2014)

Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020
por: Lewis, Nicola S., et al.
Publicado: (2021)

H5N1
por: Petsko, Gregory A
Publicado: (2005)

A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses
por: De Marco, Donata, et al.
Publicado: (2012)

A Critical HA1 Neutralizing Domain of H5N1 Influenza in an Optimal Conformation Induces Strong Cross-Protection
por: Du, Lanying, et al.
Publicado: (2013)

MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization
por: Kreijtz, Joost H. C. M., et al.
Publicado: (2009)

A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
por: Temperton, Nigel J., et al.
Publicado: (2007)

Neutralizing immune responses induced by oligomeric H5N1-hemagglutinins from plants
por: Phan, Hoang Trong, et al.
Publicado: (2017)

A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses
por: Du, Lanying, et al.
Publicado: (2011)

Phylogeography of influenza A H5N1 clade 2.2.1.1 in Egypt
por: Scotch, Matthew, et al.
Publicado: (2013)

302. Investigating NAI Titer as a Neutralizing IAV Correlate of Protection
por: Rumfelt, Kalee E, et al.
Publicado: (2023)

Cross-Neutralizing Antibodies to Pandemic 2009 H1N1 and Recent Seasonal H1N1 Influenza A Strains Influenced by a Mutation in Hemagglutinin Subunit 2
por: Wang, Wei, et al.
Publicado: (2011)

Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase
por: Tsai, Cheguo, et al.
Publicado: (2009)

SARS and H5N1
por: Bindenagel Šehović, Annamarie
Publicado: (2017)

Phylodynamics of avian influenza clade 2.2.1 H5N1 viruses in Egypt
por: Arafa, Abdelsatar, et al.
Publicado: (2016)

Cross‐neutralisation of antibodies elicited by an inactivated split‐virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains
por: Höschler, Katja, et al.
Publicado: (2008)

Detection of Extensive Cross-Neutralization between Pandemic and Seasonal A/H1N1 Influenza Viruses Using a Pseudotype Neutralization Assay
por: Labrosse, Béatrice, et al.
Publicado: (2010)

Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin
por: Schmeisser, Falko, et al.
Publicado: (2012)

Highly pathogenic avian influenza virus incursions of subtype H5N8, H5N5, H5N1, H5N4, and H5N3 in Germany during 2020-21
por: King, Jacqueline, et al.
Publicado: (2022)

Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system
por: Friel, Damien, et al.
Publicado: (2020)

A Replicating Modified Vaccinia Tiantan Strain Expressing an Avian-Derived Influenza H5N1 Hemagglutinin Induce Broadly Neutralizing Antibodies and Cross-Clade Protective Immunity in Mice
por: Xiao, Haixia, et al.
Publicado: (2013)

Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2)
por: te Beest, Dennis E., et al.
Publicado: (2017)

Structural and Antigenic Variation among Diverse Clade 2 H5N1 Viruses
por: Shore, David A., et al.
Publicado: (2013)

Experimental infection and pathology of clade 2.2 H5N1 virus in gulls
por: Gulyaeva, Marina A., et al.
Publicado: (2016)

The antibody landscapes following AS03 and MF59 adjuvanted H5N1 vaccination
por: Goll, Johannes B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dd9fpd39rgg7re440apsemfq04